So this misleading info comes from Finfeed then... because in the original paper refered to, no mention of Progenza or any anti-inflammatory treatment.
https://www.sciencedirect.com/science/article/pii/S0140673620303007
This doesn't mean Progenza is not suited for ARDS, but it's far from becoming a treatment for Covid.
Ann: Regeneus signs MOU with Kyocera Corporation, page-20
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.020(4.76%) |
Mkt cap ! $4.772M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.0¢ | 40.0¢ | $2.069K | 5.062K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8915 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1910 | 1 |
View Market Depth
| Last trade - 10.11am 29/07/2024 (20 minute delay) ? |
| CMB (ASX) Chart |